These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 15978574

  • 1. Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleus.
    Roberts C, Hagan JJ, Bartoszyk GD, Kew JN.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):59-63. PubMed ID: 15978574
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 04; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.
    Ashby CR, Kehne JH, Bartoszyk GD, Renda MJ, Athanasiou M, Pierz KA, Seyfried CA.
    Eur J Pharmacol; 2013 Aug 15; 714(1-3):359-65. PubMed ID: 23872377
    [Abstract] [Full Text] [Related]

  • 5. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, Middlemiss DN.
    Br J Pharmacol; 2001 Jul 15; 133(6):797-806. PubMed ID: 11454652
    [Abstract] [Full Text] [Related]

  • 6. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 15; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 7. 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus.
    Starkey SJ, Skingle M.
    Neuropharmacology; 1994 Sep 15; 33(3-4):393-402. PubMed ID: 7984277
    [Abstract] [Full Text] [Related]

  • 8. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935.
    Sprouse J, Reynolds L, Rollema H.
    Neuropharmacology; 1997 Sep 15; 36(4-5):559-67. PubMed ID: 9225281
    [Abstract] [Full Text] [Related]

  • 9. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
    Mundey MK, Fletcher A, Marsden CA.
    Br J Pharmacol; 1996 Feb 15; 117(4):750-6. PubMed ID: 8646424
    [Abstract] [Full Text] [Related]

  • 10. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J, De Montigny C, Blier P.
    Synapse; 1999 Dec 15; 34(4):277-89. PubMed ID: 10529722
    [Abstract] [Full Text] [Related]

  • 11. Consequences of 5-HT re-uptake blockade on postsynaptic 5-HT1A receptor activation: an electrophysiological and neurochemical study in guinea pig dorsal raphe and hippocampus.
    Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H.
    Ann N Y Acad Sci; 1998 Dec 15; 861():272-3. PubMed ID: 9928286
    [No Abstract] [Full Text] [Related]

  • 12. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
    Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H.
    Synapse; 2001 Jul 15; 41(1):49-57. PubMed ID: 11354013
    [Abstract] [Full Text] [Related]

  • 13. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice.
    Bortolozzi A, Amargós-Bosch M, Toth M, Artigas F, Adell A.
    J Neurochem; 2004 Mar 15; 88(6):1373-9. PubMed ID: 15009637
    [Abstract] [Full Text] [Related]

  • 14. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA, Metzler CW, Mirescu C, Stein SK, Jacobs BL.
    Neuropsychopharmacology; 2001 Dec 15; 25(6):858-70. PubMed ID: 11750179
    [Abstract] [Full Text] [Related]

  • 15. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 16. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphé nuclei.
    Hopwood SE, Stamford JA.
    Neuropharmacology; 2001 Mar 24; 40(4):508-19. PubMed ID: 11249960
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA, Markou A.
    J Pharmacol Exp Ther; 2001 Apr 24; 297(1):316-25. PubMed ID: 11259559
    [Abstract] [Full Text] [Related]

  • 18. EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties.
    Bartoszyk GD, Hegenbart R, Ziegler H.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):147-53. PubMed ID: 9098681
    [Abstract] [Full Text] [Related]

  • 19. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L, Mocaër E, Bertaglia A, Samanin R.
    Neuropharmacology; 2000 Apr 03; 39(6):1037-43. PubMed ID: 10727714
    [Abstract] [Full Text] [Related]

  • 20. Effects of 21 days treatment with fluoxetine on stimulated endogenous 5-hydroxytryptamine overflow in the rat dorsal raphe and suprachiasmatic nucleus studied using fast cyclic voltammetry in vitro.
    O'Connor JJ, Kruk ZL.
    Brain Res; 1994 Mar 21; 640(1-2):328-35. PubMed ID: 8004461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.